Citation Impact

Citing Papers

The Classical Complement Pathway: Activation and Regulation of the First Complement Component
1985
The Immunopathology of Joint Inflammation in Rheumatoid Arthritis
1973
Cutaneous Wound Healing
1999 Standout
Influence of a specific 5-HT3 antagonist on carrageenan-induced hyperalgesia in rats
1989
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
The genome sequence of Rickettsia prowazekii and the origin of mitochondria
1998 StandoutNature
Gout
2009 Standout
Thrombin signalling and protease-activated receptors
2000 StandoutNature
MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals
2006
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Receptor mediation of 5-HT-induced inflammation and nociception in rats
1992
Gout: Update on Some Pathogenic and Clinical Aspects
2006
Kinin receptors in pain and inflammation
2001
Complement
2001 Standout
Noxious Cold Ion Channel TRPA1 Is Activated by Pungent Compounds and Bradykinin
2004 StandoutNobel
Homocysteine and Atherothrombosis
1998 Standout
Complement recruitment using bispecific diabodies
1997 StandoutNobel
Differential RNA splicing and post-translational cleavages in the human salivary proline-rich protein gene system.
1985 StandoutNobel
Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs
1969 StandoutNatureNobel
Oxidative inactivation of leukotriene C 4 by stimulated human polymorphonuclear leukocytes
1982 StandoutNobel
Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene.
1990
Activation of Hageman Factor by L-Homocystine
1968 Science
Thrombin functions as an inflammatory mediator through activation of its receptor.
1996
Serpin Structure, Mechanism, and Function
2002 Standout
Methionyl-lysyl-bradykinin, a new kinin from ox blood
1965
Kallidin, Synthese und Eigenschaften. (Vorläufige Mitteilung)
1962
Inactivation of Prostaglandins by the Lungs
1970 StandoutNatureNobel
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 StandoutScienceNobel
Pharmacologic and Endocrine Aspects of Carcinoid Syndrome
1967
The 5-HT3Subtype of Serotonin Receptor Contributes to Nociceptive Processing via a Novel Subset of Myelinated and Unmyelinated Nociceptors
2002 StandoutNobel
Contribution of Intrarenal Generation of Prostaglandin to Autoregulation of Renal Blood Flow in the Dog
1973 StandoutNobel
Slow‐reacting substance of anaphylaxis Purification and characterisation
1978
The synthesis of a biologically active decapeptide having the structure proposed for kallidin II
1961
A biochemical abnormality in hereditary angioneurotic edema
1963 Standout
The role of glandular kallikrein in the formation of a salivary proline-rich protein A by cleavage of a single bond in salivary protein C.
1983
Phytohemagglutinin: Inhibition of the Agglutinating Activity by N -Acetyl-D-Galactosamine
1966 Science
Leukotriene D: a slow reacting substance from rat basophilic leukemia cells.
1980 StandoutNobel
FUNCTIONAL EVIDENCE FOR THE EXISTENCE OF A THIRD CELL TYPE IN THE RENAL GLOMERULUS
1962 StandoutNobel
A genome-wide analysis of immune responses in Drosophila
2001 StandoutNobel
SEROTONIN IMMUNOREACTIVITY IN CARCINOID TUMOURS DEMONSTRATED BY A MONOCLONAL ANTIBODY
1982 StandoutNobel
Genetic Aspects of the Complement System
1971
Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 ‘reactive centre’ (Arg444→His) mutation
1988
Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells.
1977
STUDIES ON THE O ANTIGEN OF SALMONELLA TYPHOSA
1956
Some Properties of Angiotensin Converting Enzyme in the Lung in vivo
1970 StandoutNatureNobel
KININS OF DIFFERENT ORIGINS
1963
Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.
1981 StandoutNobel
A novel leukotriene produced by stimulation of leukocytes with formylmethionylleucylphenylalanine.
1982 StandoutNobel
Chemistry and Reaction Mechanisms of Complement
1968
Prostacyclin is a circulating hormone
1978 StandoutNatureNobel
The role of endotoxin in protection of adult rats from oxygen-induced lung toxicity.
1978 StandoutNobel
Anoxia-induced release of prostaglandins in rabbit isolated hearts.
1975 StandoutNobel
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
1979 StandoutNobel
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
1984 StandoutNobel
THE RELATIONSHIP BETWEEN THE VASCULAR MANIFESTATIONS OF SHOCK PRODUCED BY ENDOTOXIN, TRAUMA, AND HEMORRHAGE
1957 StandoutNobel
Pathogenesis of Gout
2005
Modification of the Single Tryptophan Residue of Staphylococcal Nuclease by a New Mild Oxidizing Agent
1970 StandoutNobel
Leukotrienes are potent constrictors of human bronchi
1980 StandoutNatureNobel
Sequence analysis and molecular characterization of genes required for the biosynthesis of type 1 capsular polysaccharide in Staphylococcus aureus
1994
Genetic Polymorphism of C′3(β 1C -Globulin) in Human Serum
1968 StandoutScienceNobel
The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system
1990
Bee and Wasp Venoms
1972 StandoutScience
Affinity purification of synthetic peptides.
1976 StandoutNobel
Selective Cleavage and Modification of Peptides and Proteins
1970
In Vitro Assay of Endotoxin by the Inhibition of Macrophage Migration
1967
Bradykinin, kallidin, and their synthetic analogues
1964
GENETIC CONTROL OF THYMUS-DERIVED CELL FUNCTION
1972 StandoutNobel
Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint
1975 StandoutNobel
Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey
1982 StandoutNatureNobel
PHARMACOLOGIC ENHANCEMENT OF WOUND HEALING
1995
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
1984 StandoutNobel
Automated Synthesis of Peptides
1965 StandoutScienceNobel
THE FIXATION OF COMPLEMENT AND THE ACTIVATED FIRST COMPONENT (C1) OF COMPLEMENT BY COMPLEXES FORMED BETWEEN ANTIBODY AND DIVALENT HAPTEN
1970 StandoutNobel
Automated Peptide Synthesis
1965 StandoutNatureNobel
Biological Sciences: Blood Concentration of Noradrenaline in the Dog after Intravenous Administration and the Effects of Desipramine
1971 StandoutNatureNobel
Pathogenesis of Experimental Shock: I. Absence of Morphologic Evidence for Bacterial Endotoxemia.
1960 StandoutNobel
Evolution at Two Levels in Humans and Chimpanzees
1975 StandoutScience
Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma
1982
Leukotriene A. Isolation from human polymorphonuclear leukocytes.
1980 StandoutNobel
The release and fate of vaso‐active hormones in the circulation
1969 StandoutNobel
Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse
1959 StandoutNatureNobel
Endotoxin and prevention of hypoxic pulmonary vasoconstriction.
1976

Works of Marion E. Webster being referenced

Studies on the O Antigen of Salmonella Typhosa
1955
STUDIES ON PLASMA KALLIKREIN AND ITS RELATIONSHIP TO PLASMIN
1960
INFLAMMATION INDUCED BY HISTAMINE, SEROTONIN, BRADYKININ AND COMPOUND 48/80 IN THE RAT: ANTAGONISTS AND MECHANISMS OF ACTION
1974
Studies on Vi antigen. II. Purification of Vi antigen from Escherichia coli 5395/38.
1952
Separation of Slow Reacting Substance of Anaphylaxis (SRS-A) from Human Lung Into Four Biologically Active Fractions
1976
Studies on the O antigen of Salmonella typhosa. I. Purification of the antigen.
1955
D‐Galaktosaminuronsäure (2‐Amino‐2‐desoxy‐D‐galakturonsäure) als Baustein des Vi‐Antigens
1959
Role of Hageman Factor in the Activation of Vasodilator Activity in Human Plasma
1961 Nature
Action of the Kallikreins on Synthetic Ester Substrates
1961
Urate Crystal Induced Inflammation in the Rat: Evidence for the Combined Actions of Kinins, Histamine and Components of Complement
1972
Studies on the O antigen of Salmonella typhosa. II. Immunological properties of the purified antigen.
1955
Clinical trials with purified platelet releasate.
1991
Human plasma kallidins: Isolation and chemical studies
1961
The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies
1967
Interaction of leukocytes and endotoxin with the plasmin and kinin systems
1975
Hereditary angioneurotic edema
1962
THE NATURE OF THE KALLIDINS RELEASED FROM HUMAN PLASMA BY KALLIKREINS AND OTHER ENZYMES
1963
Release of kinin activity from human kininogens and fresh plasma by cyanogen bromide
1966
Rankless by CCL
2026